Bavarian Nordic (OTCMKTS:BVNRY - Get Free Report) shares gapped up before the market opened on Thursday . The stock had previously closed at $9.12, but opened at $9.48. Bavarian Nordic shares last traded at $9.47, with a volume of 963 shares traded.
Bavarian Nordic Trading Down 0.7%
The business's 50-day simple moving average is $8.75 and its 200-day simple moving average is $8.34. The company has a market capitalization of $2.24 billion, a PE ratio of 11.81 and a beta of 1.36.
Bavarian Nordic (OTCMKTS:BVNRY - Get Free Report) last announced its quarterly earnings results on Friday, May 9th. The company reported $0.13 EPS for the quarter. The company had revenue of $189.89 million for the quarter. Bavarian Nordic had a net margin of 21.11% and a return on equity of 11.89%. Sell-side analysts forecast that Bavarian Nordic will post 0.67 EPS for the current fiscal year.
About Bavarian Nordic
(
Get Free Report)
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.
Featured Articles
Before you consider Bavarian Nordic, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bavarian Nordic wasn't on the list.
While Bavarian Nordic currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
